MacroGenics (MGNX): Stock Price

MacroGenics, Inc. (MGNX) develops innovative breast cancer treatments, leveraging partnerships with major pharmaceutical companies to engineer antibodies. This chart of market value featuring the 2.33 metric demonstrates the price action of an asset whose US operations are shielded from external conflicts by the humanitarian status of medicine. However, the business faces intense pressure from global behemoths and the risk of affordable therapeutic alternatives emerging.

Share Price: macrogenics.com (MGNX) for 07/04/2022 - 11/12/2026

Analytical breakdowns for MacroGenics Inc (MGNX)

- stock value and consensus price forecast:

Price Chart MacroGenics, Inc.|MGNX - Consensus Target

- stock exchange capitalization data:

Market Capitalization MacroGenics Inc|MGNX - Full Takeover Company Value

- book capitalization information:

Net Assets per Single Share MacroGenics|MGNX - Accounting Capitalization|Market Cap to Net Assets Ratio macrogenics.com|MGNX - Total Business Assets

- debt and liquidity data:

- company profitability and valuation multiples indicators:

MGNX - Net Financial Result|Future Profit MacroGenics, Inc.|MGNX - Market Price to Net Income Ratio|Projected Price to Earnings MacroGenics|MGNX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple MacroGenics Inc|MGNX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) MacroGenics|MGNX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months macrogenics.com|MGNX - Earnings per share growth this year|Earnings growth forecast for next year MacroGenics, Inc.

Fundamental valuation:MacroGenics, Inc.

Analyzing the price trajectory of MacroGenics, Inc. (MGNX), an investor observes a market valuation of the business formed through the real-time balance of stock demand and supply. This indicator reflects the capital consensus regarding the sustainability of cash flows from approved oncology drugs and royalties, where stable medical demand serves as the foundation for the company's long-term capitalization.

Competitors of MacroGenics, Inc. (MGNX)